ACTR1A
Basic information
Region (hg38): 10:102461881-102502712
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACTR1A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 5 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 5 | 0 | 0 |
Variants in ACTR1A
This is a list of pathogenic ClinVar variants found in the ACTR1A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-102471284-A-T | not specified | Uncertain significance (Oct 29, 2021) | ||
10-102471332-G-A | not specified | Likely benign (Jul 06, 2021) | ||
10-102473825-C-T | Likely benign (Dec 01, 2022) | |||
10-102473849-G-C | not specified | Uncertain significance (Jul 08, 2021) | ||
10-102482002-T-A | not specified | Uncertain significance (Oct 25, 2022) | ||
10-102482123-A-G | not specified | Uncertain significance (Mar 12, 2024) | ||
10-102484227-T-C | not specified | Uncertain significance (Mar 29, 2022) | ||
10-102484230-A-T | not specified | Uncertain significance (Aug 17, 2022) | ||
10-102484243-G-A | not specified | Uncertain significance (Mar 21, 2024) | ||
10-102488184-T-C | not specified | Uncertain significance (Oct 12, 2022) | ||
10-102489138-A-G | not specified | Likely benign (May 12, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACTR1A | protein_coding | protein_coding | ENST00000369905 | 11 | 23497 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.966 | 0.0338 | 125730 | 0 | 4 | 125734 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.03 | 100 | 229 | 0.437 | 0.0000141 | 2449 |
Missense in Polyphen | 30 | 96.569 | 0.31066 | 1034 | ||
Synonymous | 1.60 | 70 | 89.2 | 0.785 | 0.00000575 | 753 |
Loss of Function | 3.94 | 3 | 23.7 | 0.126 | 0.00000148 | 244 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000467 | 0.0000462 |
European (Non-Finnish) | 0.00000879 | 0.00000879 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000390 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of a multi-subunit complex involved in microtubule based vesicle motility. It is associated with the centrosome.;
- Pathway
- Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Regulation of PLK1 Activity at G2/M Transition;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;Recruitment of mitotic centrosome proteins and complexes;Loss of Nlp from mitotic centrosomes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;AURKA Activation by TPX2;G2/M Transition;Mitotic G2-G2/M phases;COPI-independent Golgi-to-ER retrograde traffic;Golgi-to-ER retrograde transport;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;COPI-mediated anterograde transport;M Phase;Cell Cycle;ER to Golgi Anterograde Transport;Cell Cycle, Mitotic;Anchoring of the basal body to the plasma membrane;Intra-Golgi and retrograde Golgi-to-ER traffic;Cilium Assembly;Organelle biogenesis and maintenance
(Consensus)
Recessive Scores
- pRec
- 0.546
Intolerance Scores
- loftool
- 0.266
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 28.63
Haploinsufficiency Scores
- pHI
- 0.304
- hipred
- Y
- hipred_score
- 0.749
- ghis
- 0.599
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.965
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Actr1a
- Phenotype
Gene ontology
- Biological process
- G2/M transition of mitotic cell cycle;endoplasmic reticulum to Golgi vesicle-mediated transport;spermatogenesis;regulation of G2/M transition of mitotic cell cycle;vesicle-mediated transport;antigen processing and presentation of exogenous peptide antigen via MHC class II;ciliary basal body-plasma membrane docking
- Cellular component
- manchette;cytoplasm;centrosome;centriole;cytosol;dynactin complex;microtubule associated complex;microtubule cytoskeleton;COPI-coated vesicle;myelin sheath;extracellular exosome;cell cortex region
- Molecular function
- protein binding;ATP binding